Nephroma is a type of cancer that affects the kidneys. It is a relatively rare condition, with only about 1,000 new cases reported each year in the United States. Despite its rarity, nephroma is a serious and potentially life-threatening disease. It is important for doctors to be aware of the signs, symptoms, and treatments of nephroma in order to provide the best possible care for their patients. This article will provide an overview of nephroma, including its symptoms, diagnosis, and treatment options.
Nephroma is a type of cancer that affects the kidneys. It is a malignant tumor, meaning it can spread to other parts of the body. The most common type of nephroma is called renal cell carcinoma, which accounts for about 90% of all kidney cancers. Other types of nephroma include Wilms tumor, transitional cell carcinoma, and renal sarcoma.
Nephroma can cause a variety of signs and symptoms, depending on the type and stage of the disease. Common signs and symptoms include: • Blood in the urine • Abdominal pain • Loss of appetite • Weight loss • Fatigue • Fever • Swelling in the abdomen or legs
In order to diagnose nephroma, doctors will first perform a physical exam and ask about the patient’s medical history. They may also order additional tests, such as imaging scans (CT, MRI, or ultrasound) or a biopsy. A biopsy involves taking a sample of the tumor and examining it under a microscope to determine if it is cancerous.
The treatment of nephroma depends on the type and stage of the disease. Treatment options may include surgery, radiation therapy, chemotherapy, and targeted therapy. Surgery is the most common treatment for nephroma, and it may involve removing the entire tumor or just part of it. Radiation therapy and chemotherapy are used to kill any remaining cancer cells. Targeted therapy is a newer type of treatment that uses drugs to target specific cancer cells.
Nephroma is a rare but serious type of cancer that can affect the kidneys. Early detection and treatment are key to improving the chances of a successful outcome. It is important for doctors to be aware of the signs, symptoms, and treatment options of nephroma in order to provide the best possible care for their patients. With the right diagnosis and treatment, patients with nephroma can lead healthy and active lives.
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation